Cargando…
Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
[Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756786/ https://www.ncbi.nlm.nih.gov/pubmed/31559376 http://dx.doi.org/10.1021/acsomega.8b03415 |
_version_ | 1783453463253876736 |
---|---|
author | Lindenblatt, Dirk Nickelsen, Anna Applegate, Violetta M. Hochscherf, Jennifer Witulski, Benedict Bouaziz, Zouhair Marminon, Christelle Bretner, Maria Le Borgne, Marc Jose, Joachim Niefind, Karsten |
author_facet | Lindenblatt, Dirk Nickelsen, Anna Applegate, Violetta M. Hochscherf, Jennifer Witulski, Benedict Bouaziz, Zouhair Marminon, Christelle Bretner, Maria Le Borgne, Marc Jose, Joachim Niefind, Karsten |
author_sort | Lindenblatt, Dirk |
collection | PubMed |
description | [Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by certain ATP-competitive ligands. Here, we present THN27, an indeno[1,2-b]indole derivative, as a further inhibitor with basal isoform selectivity. The selectivity disappears when measured using CK2α/CK2α′ complexes with CK2β, the regulatory CK2 subunit. Co-crystal structures of THN27 with CK2α and CK2α′ reveal that subtle differences in the conformational variability of the interdomain hinge region are correlated with the observed effect. In the case of CK2α′, a crystallographically problematic protein so far, this comparative structural analysis required the development of an experimental strategy that finally enables atomic resolution structure determinations with ab initio phasing of potentially any ATP-competitive CK2 inhibitor and possibly many non-ATP-competitive ligands as well bound to CK2α′. |
format | Online Article Text |
id | pubmed-6756786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-67567862019-09-26 Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures Lindenblatt, Dirk Nickelsen, Anna Applegate, Violetta M. Hochscherf, Jennifer Witulski, Benedict Bouaziz, Zouhair Marminon, Christelle Bretner, Maria Le Borgne, Marc Jose, Joachim Niefind, Karsten ACS Omega [Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by certain ATP-competitive ligands. Here, we present THN27, an indeno[1,2-b]indole derivative, as a further inhibitor with basal isoform selectivity. The selectivity disappears when measured using CK2α/CK2α′ complexes with CK2β, the regulatory CK2 subunit. Co-crystal structures of THN27 with CK2α and CK2α′ reveal that subtle differences in the conformational variability of the interdomain hinge region are correlated with the observed effect. In the case of CK2α′, a crystallographically problematic protein so far, this comparative structural analysis required the development of an experimental strategy that finally enables atomic resolution structure determinations with ab initio phasing of potentially any ATP-competitive CK2 inhibitor and possibly many non-ATP-competitive ligands as well bound to CK2α′. American Chemical Society 2019-03-19 /pmc/articles/PMC6756786/ /pubmed/31559376 http://dx.doi.org/10.1021/acsomega.8b03415 Text en Copyright © 2019 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Lindenblatt, Dirk Nickelsen, Anna Applegate, Violetta M. Hochscherf, Jennifer Witulski, Benedict Bouaziz, Zouhair Marminon, Christelle Bretner, Maria Le Borgne, Marc Jose, Joachim Niefind, Karsten Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures |
title | Diacritic Binding of an Indenoindole Inhibitor by
CK2α Paralogs Explored by a Reliable Path to Atomic Resolution
CK2α′ Structures |
title_full | Diacritic Binding of an Indenoindole Inhibitor by
CK2α Paralogs Explored by a Reliable Path to Atomic Resolution
CK2α′ Structures |
title_fullStr | Diacritic Binding of an Indenoindole Inhibitor by
CK2α Paralogs Explored by a Reliable Path to Atomic Resolution
CK2α′ Structures |
title_full_unstemmed | Diacritic Binding of an Indenoindole Inhibitor by
CK2α Paralogs Explored by a Reliable Path to Atomic Resolution
CK2α′ Structures |
title_short | Diacritic Binding of an Indenoindole Inhibitor by
CK2α Paralogs Explored by a Reliable Path to Atomic Resolution
CK2α′ Structures |
title_sort | diacritic binding of an indenoindole inhibitor by
ck2α paralogs explored by a reliable path to atomic resolution
ck2α′ structures |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756786/ https://www.ncbi.nlm.nih.gov/pubmed/31559376 http://dx.doi.org/10.1021/acsomega.8b03415 |
work_keys_str_mv | AT lindenblattdirk diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT nickelsenanna diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT applegateviolettam diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT hochscherfjennifer diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT witulskibenedict diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT bouazizzouhair diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT marminonchristelle diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT bretnermaria diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT leborgnemarc diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT josejoachim diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures AT niefindkarsten diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures |